PYC Therapeutics | PYC - Stammkapital

Aktienkurs
1.44
Täglich Wechseln
-0.002 -0.14%
Monatlich
18.84%
Jährlich
16.91%
Q2 Prognose
1.21




Stammkapital Veränderung Datum
Medical Developments International AUD 112.66M 2.35M 2025-12
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Pacific Edge NZD 1.02B 210.22M 2025-12
Paradigm Biopharmaceuticals AUD 428.52M 39.09M 2025-12
Telix Pharmaceuticals AUD 338.78M 379K 2025-12